Enliven Therapeutics
ELVN
#5218
Rank
HK$9.40 B
Marketcap
HK$199.09
Share price
5.84%
Change (1 day)
85.87%
Change (1 year)

Enliven Therapeutics (ELVN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : HK$0.17 B

According to Enliven Therapeutics's latest financial reports the company's total liabilities are HK$0.17 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Enliven Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$0.20 B-83.79%
2022-12-31HK$1.25 B2.71%
2021-12-31HK$1.21 B3.83%
2020-12-31HK$1.17 B